跳至主要内容
临床试验/ISRCTN26184967
ISRCTN26184967已完成未知

A multicentre, randomised, superiority study to compare the efficacy of video observed treatment (VOT) versus directly observed treatment (DOT) in supporting adherence in patients with active tuberculosis

niversity College London0 个研究点目标入组 226 人开始时间: 2014年4月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
226

研究概览

简要总结

2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30799062 (added 08/05/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Any TB patient aged 16 years or older seen at participating clinics who meets national or local guidance for DOT and are assessed to be eligible for DOT.
  • Target Gender: Male & Female ; Lower Age Limit 16 years

排除标准

  • 1. Patients who are eligible for DOT but not suitable for VOT due to:
  • 1.1. Need for intravenous treatment
  • 1.2. No access to the facilities to charge a smartphone
  • 2. Patients in whom the primary outcome cannot be measured because they have less than 2 months of treatment remaining
  • 3. MDRTB patients requiring more than once daily treatment who will be recruited into a non-randomised arm of the study where VOT is offered, with the same follow up as the other study arms. This represents small numbers of patients and is planned because DOT is highly difficult to organise in this group and VOT is therefore already considered the optimal arrangement

研究者

发起方
niversity College London

相似试验